Company Overview of Reckitt Benckiser Pharmaceuticals, Inc.
Reckitt Benckiser Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company offers opioid medication under the brand name Suboxone and sublingual tablets under the brand name Subutex. Reckitt Benckiser Pharmaceuticals, Inc. was formerly known as Reckitt & Colman Pharmaceuticals, Inc. The company was incorporated in 1997 and is based in Richmond, Virginia. Reckitt Benckiser Pharmaceuticals, Inc. operates as a subsidiary of Reckitt Benckiser Group plc.
The Fairfax Building
10710 Midlothian Turnpike
Richmond, VA 23235
Founded in 1997
Key Executives for Reckitt Benckiser Pharmaceuticals, Inc.
Chief Executive Officer and President
Compensation as of Fiscal Year 2015.
Reckitt Benckiser Pharmaceuticals, Inc. Key Developments
Reckitt Benckiser Pharmaceuticals, Inc. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 10:40 AM
Nov 19 14
Reckitt Benckiser Pharmaceuticals, Inc. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 10:40 AM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom.
Reckitt Benckiser Pharmaceuticals Inc. Appoints Cary J. Claiborne as Chief Financial Officer, effective November 10, 2014
Nov 4 14
Reckitt Benckiser Pharmaceuticals Inc. announced appointment of Cary J. Claiborne as Chief Financial Officer. Cary will lead the company's global financial and information technology operations, reporting to Chief Executive Officer Shaun Thaxter effective November 10, 2014. Prior to his appointment at Reckitt Benckiser Pharmaceuticals, Cary served as Chief Financial Officer of Sucampo Pharmaceuticals Inc.
AntiOp, Inc. Partners with Reckitt Benckiser Pharmaceuticals, Inc. to Develop Nasally Administered Treatment for Opioid Overdose
May 21 14
AntiOp, Inc. has signed an agreement with Reckitt Benckiser Pharmaceuticals, Inc. to accelerate production and worldwide marketing of intranasal naloxone, a drug designed to treat opioid overdose. This partnership leverages the combined resources and strengths. The Centers for Disease Control's recent statistics indicate a steadily increasing number of deaths due to opioid overdose. The number has tripled since 1990, with a more recent statistic citing 16,500 deaths in the U.S. from prescription opioids alone, principally painkillers such as hydrocodone, methadone, oxycodone and oxymorphone. Related statistics show approximately 800,000 ambulance runs in the U.S. each year related to suspected opioid overdoses involving both prescription opioids and heroin.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|